These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38033962)

  • 1. The emerging concern of oral pemphigus vulgaris arising post-COVID-19 infection: A case series.
    Gunardi I; Hartanto FK; Amtha R; Nadiah N; Sari EF
    J Oral Maxillofac Pathol; 2023; 27(3):557-561. PubMed ID: 38033962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune mucocutaneous blistering diseases after SARS-Cov-2 vaccination: A Case report of Pemphigus Vulgaris and a literature review.
    Calabria E; Canfora F; Mascolo M; Varricchio S; Mignogna MD; Adamo D
    Pathol Res Pract; 2022 Apr; 232():153834. PubMed ID: 35278817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pemphigus Vulgaris After COVID-19: a Case of Induced Autoimmunity.
    De Medeiros VLS; Monteiro-Neto AU; França DDT; Castelo Branco R; de Miranda Coelho ÉO; Takano DM
    SN Compr Clin Med; 2021; 3(8):1768-1772. PubMed ID: 34075351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.
    Akoglu G
    Dermatol Ther; 2022 May; 35(5):e15396. PubMed ID: 35187768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pemphigus Vulgaris Possibly Associated with COVID-19 Infection.
    Kim YH; Kang HY
    Cureus; 2023 Jan; 15(1):e33897. PubMed ID: 36819405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe acute respiratory syndrome coronavirus 2 infection in patients with autoimmune bullous diseases in China.
    Zhang JL; Wang SH; Cui SN; Zhang J; Li SZ; Li L; Zuo YG
    J Dermatol; 2023 Nov; 50(11):1433-1441. PubMed ID: 37501390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.
    Beyzaee AM; Rahmatpour Rokni G; Patil A; Goldust M
    Dermatol Ther; 2021 Jan; 34(1):e14405. PubMed ID: 33051960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 infection as a trigger of autoimmune response.
    Sacchi MC; Tamiazzo S; Stobbione P; Agatea L; De Gaspari P; Stecca A; Lauritano EC; Roveta A; Tozzoli R; Guaschino R; Bonometti R
    Clin Transl Sci; 2021 May; 14(3):898-907. PubMed ID: 33306235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune bullous disorder flares following severe acute respiratory syndrome coronavirus 2 vaccination: a case series.
    Rasner CJ; Schultz B; Bohjanen K; Pearson DR
    J Med Case Rep; 2023 Sep; 17(1):408. PubMed ID: 37749657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis and Treatment Challenges of an Atypical Case of Pemphigus vulgaris During the COVID-19 Pandemic.
    Banciu ML; Dobrica C; Malciu AM; Vâjâitu C; Voiculescu VM
    Cureus; 2022 Jan; 14(1):e21739. PubMed ID: 35251811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema multiforme-like lip presentation in pemphigus vulgaris patients: a multicenter case series.
    Subahi G; Waheeb S; Binmadi N; Almazrooa S; Akeel S; Öhman J; Dafar A
    BMC Oral Health; 2023 Dec; 23(1):952. PubMed ID: 38041037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune skin disorders and SARS-CoV-2 vaccination - a meta-analysis.
    Hinterseher J; Hertl M; Didona D
    J Dtsch Dermatol Ges; 2023 Aug; 21(8):853-861. PubMed ID: 37218538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID outcome in pemphigus: Does rituximab make pemphigus patients susceptible to more severe COVID-19?
    Aryanian Z; Balighi K; Sajad B; Esmaeli N; Daneshpazhooh M; Mazloumi Tootoonchi N; Beigmohammadi F; Mohseni Afshar Z; Hatami P
    J Cosmet Dermatol; 2023 Nov; 22(11):2880-2888. PubMed ID: 37573477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pemphigus vulgaris relapse during the coronavirus disease pandemic.
    Saleh MA; Saleh NA
    Dermatol Ther; 2022 Apr; 35(4):e15354. PubMed ID: 35108427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 and exacerbation of dermatological diseases: A review of the available literature.
    Aram K; Patil A; Goldust M; Rajabi F
    Dermatol Ther; 2021 Nov; 34(6):e15113. PubMed ID: 34453380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes.
    Valencia Sanchez C; Theel E; Binnicker M; Toledano M; McKeon A
    Neurology; 2021 Dec; 97(23):e2262-e2268. PubMed ID: 34635560
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.